Clinical Nuclear Medicine · 2022 · 10 citations · 11 references
MedicineOncologyRadiologyDiagnostic ImagingDiagnostic RadiologyMetastasisMolecular Imaging In OncologyOncologic Hybrid ImagingOncologic Nuclear ImagingPancreatic CancerPositron Emission TomographyTumor ImagingFibroblast ActivationFibroblast Activation Protein ImagingLocal Tumor RecurrenceMetastatic Pancreatic CancerMetastatic Tumor DetectionOncologic Pet ImagingPancreatic Cancer ImagingPancreatic Metastases
ABSTRACT: Recently imaging with new PET radiotracers that act as fibroblast activation protein inhibitors (FAPIs) showed promising results in oncology and even nononcology imaging. Here we report a case of advanced pancreatic adenocarcinoma, imaged with both 18 F-FDG and 68 Ga-FAPI-46 PET/CT scans. The result indicated that imaging with 68 Ga-FAPI-46 showed significant improvement in detection of metastases as well as local malignancy recurrence. Moreover, the intensity and SUVs of the lesions were higher in 68 Ga-FAPI-46 scan compared with 18 F-FDG.
11
<sup>68</sup>Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer
Clemens Kratochwil, Paul Flechsig, Thomas Lindner et al. · Journal of Nuclear Medicine · 2019 · 1.4K citations · Full text
Medicine, Nuclear Medicine, Oncology +17
Frederik L. Giesel, Clemens Kratochwil, Thomas Lindner et al. · Journal of Nuclear Medicine · 2018 · 722 citations · Full text
Medicine, Nuclear Medicine, Oncology +17
Haojun Chen, Yizhen Pang, Jingxun Wu et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 540 citations
Yizhen Pang, Liang Zhao, Zuoming Luo et al. · Radiology · 2020 · 305 citations · Full text
Medicine, Nuclear Medicine, Oncology +17